French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
데이터 추가 비고
조치
The company CODAN France withdraws from the market the 80832 batch of the reference 62.1663 named insulin syringe following the report of an incident namely the mixing of insulin syringes with tuberculin syringes in the same cardboard labeled "insulin syringes". The 15 customers concerned (hospitals and clinics) are notified directly by the manufacturer.